Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.79 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.79 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.65 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.65 |
| ▸ | CA12 | O43570 | 2/20 | 0.62 |
| ▸ | CA1 | P00915 | 2/20 | 0.62 |
| ▸ | CA2 | P00918 | 2/20 | 0.62 |
| ▸ | CA7 | P43166 | 2/20 | 0.62 |
| ▸ | CA9 | Q16790 | 2/20 | 0.62 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.60 |
| ▸ | NCF1 | P14598 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.54 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29447161 | 1.00 | CYP1A2 (0.79) | CYP1A2CYP2A6HSD17B1HSD17B2CA12 | |
| SCHEMBL7451812 | 0.94 | CYP1A2 (0.71) | CYP1A2CYP2A6HSD17B1HSD17B2CA12 | |
| SCHEMBL7456084 | 0.94 | CYP1A2 (0.71) | CYP1A2CYP2A6HSD17B1HSD17B2CA12 | |
| SCHEMBL29367032 | 0.94 | CYP2A6 (0.80) | CYP1A2CYP2A6HSD17B1HSD17B2CA12 | |
| SCHEMBL2249185 | 0.94 | CYP1A2 (0.71) | CYP1A2CYP2A6HSD17B1HSD17B2CA12 | |
| SCHEMBL7452675 | 0.94 | CYP1A2 (0.71) | CYP1A2CYP2A6HSD17B1HSD17B2CA12 | |
| SCHEMBL6891918 | 0.94 | CYP1A2 (0.71) | CYP1A2CYP2A6HSD17B1HSD17B2CA12 | |
| SCHEMBL29919511 | 0.94 | CYP1A2 (0.71) | CYP1A2CYP2A6HSD17B1HSD17B2CA12 | |
| SCHEMBL443528 | 0.94 | CYP2A6 (0.80) | CYP1A2CYP2A6HSD17B1HSD17B2CA12 | |
| SCHEMBL22106286 | 0.91 | CYP2A6 (0.68) | CYP1A2CYP2A6HSD17B1HSD17B2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 465 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116041669-B | Epoxy resin monomer and preparation method and application thereof | 中国建筑材料科学研究总院有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-116925102-A | Multi-nitrogen bridged compound and preparation method thereof | 北京理工大学 | 2023-10-24 | — | — | CN | claimed |
| CN-116041669-A | Epoxy resin monomer and preparation method and application thereof | 中国建筑材料科学研究总院有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-115340818-A | High-performance high-temperature-resistant impregnating resin and preparation method thereof | 丹阳市沃德立电工材料有限公司 | 2022-11-15 | — | — | CN | claimed |
| CN-111808048-A | Preparation method of environment-friendly high-temperature-resistant epoxy impregnating resin | 绍兴柯桥拟泰科技有限公司 | 2020-10-23 | — | — | CN | claimed |
| CN-110746575-A | Preparation method of environment-friendly high-temperature-resistant epoxy impregnating resin | 浙江荣泰科技企业有限公司 | 2020-02-04 | — | — | CN | claimed |
| EP-3081562-A1 | COMPOUND FOR INHIBITING ACTIVITY OF GLUTATHIONE S-TRANSFERASE OMEGA 1 AND PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUND | China Medical University (TW) | 2016-10-19 | — | — | EP | claimed |
| CN-102757321-B | Production method of 2,6-dimethoxynaphthalene | NANTONG BAISHENG CHEMICAL CO LTD | 2015-06-17 | — | — | CN | claimed |
| CN-103980245-A | Compound for inhibiting glutathione S-transferase omega1 activity, preparation method thereof and pharmaceutical composition containing compound | UNIV CHINA MEDICAL | 2014-08-13 | — | — | CN | claimed |
| US-20140221470-A1 | COMPOUND FOR INHIBITING GLUTATHIONE S-TRANSFERASE OMEGA 1 ACTIVITY, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, AND METHOD FOR SYNTHESIZING THE SAME | CHINA MEDICAL UNIVERSITY (TW) | 2014-08-07 | — | — | US | claimed |
| WO-1994017985-A1 | PROCESS OF MAKING MICROPOROUS PPS MEMBRANES | THE DOW CHEMICAL COMPANY (US) | 1994-08-18 | — | — | WO | claimed |
| EP-0606198-A1 | MICROPOROUS HOLLOW FIBER OR FILM MEMBRANE OF POLY(PHENYLENE SULFIDE) (PPS) | THE DOW CHEMICAL COMPANY (US) | 1994-07-20 | — | — | EP | claimed |
| US-5266723-A | Process for the preparation of optically active 2-aryl-alkanoic acids, especially 2-aryl-propionic acids | MEDICE, LTD., CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) | 1993-11-30 | — | — | US | claimed |
| US-5246647-A | Solvent | THE DOW CHEMICAL COMPANY (US) | 1993-09-21 | — | — | US | claimed |
| US-5227101-A | Blending, heating, extruding or casting, quenching or coagulating and leaching a blend of unsulfonated polyether ketone copolymers and partially imcompatible polymer | THE DOW CHEMICAL COMPANY (US) | 1993-07-13 | — | — | US | claimed |
| US-5205968-A | Process for making a microporous membrane from a blend containing a poly(etheretherketone)-type polymer, an amorphous polymer, and a solvent | THE DOW CHEMICAL COMPANY (US) | 1993-04-27 | — | — | US | claimed |
| WO-1993004223-A1 | MICROPOROUS HOLLOW FIBER OR FILM MEMBRANE OF POLY(PHENYLENE SULFIDE) (PPS) | THE DOW CHEMICAL COMPANY (US) | 1993-03-04 | — | — | WO | claimed |
| US-5064580-A | Heating, extrusion, coagulation, leaching out of plasticizer | THE DOW CHEMICAL COMPANY (US) | 1991-11-12 | — | — | US | claimed |
| US-5043112-A | Dissolving polyphenylene sulfide in hot melted high-boiling boiling organic solvent, shaping, desolventizing, cooling | THE DOW CHEMICAL COMPANY (US) | 1991-08-27 | — | — | US | claimed |
| US-4904426-A | MOCROPOROUS; AROMATIC RING-CONTAINING SOLVENT; EXTRUSION, QUENCHING, LEACHING, DRYING | THE DOW CHEMICAL COMPANY (US) | 1990-02-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140221470-A1 | COMPOUND FOR INHIBITING GLUTATHIONE S-TRANSFERASE OMEGA 1 ACTIVITY, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, AND METHOD FOR SYNTHESIZING THE SAME | GSTO1, GSTA1, GSTP1 | CYP1A2 191/4885CYP2A6 272/4885HSD17B1 271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.